QPTFF (Quest PharmaTech) Cyclically Adjusted FCF per Share: $0.00 (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Quest PharmaTech Cyclically Adjusted FCF per Share?

Quest PharmaTech QPTFF Cyclically Adjusted FCF per Share is $0.00 as of Jan. 2026.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Quest PharmaTech's adjusted free cash flow per share for the three months ended in Jan. 2026 was $0.000. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Jan. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Quest PharmaTech was 26.30% per year. The lowest was -14.50% per year. And the median was 0.00% per year.

As of today (2026-07-14), Quest PharmaTech's current stock price is $0.02. Quest PharmaTech's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2026 was $0.00. Quest PharmaTech's Cyclically Adjusted Price-to-FCF of today is .


Quest PharmaTech  (OTCPK:QPTFF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Quest PharmaTech Cyclically Adjusted FCF per Share Related Terms


Quest PharmaTech Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Quest PharmaTech's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech Cyclically Adjusted FCF per Share Chart

Quest PharmaTech Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.03 0.00 0.00 0.00

Quest PharmaTech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.01 0.00 0.00 0.00

QPTFF vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Quest PharmaTech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Cyclically Adjusted Price-to-FCF falls into.



Quest PharmaTech Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Quest PharmaTech's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jan. 2026 (Change)*Current CPI (Jan. 2026)
=-0/130.3661*130.3661
=0.000

Current CPI (Jan. 2026) = 130.3661.

Quest PharmaTech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201604 -0.008 101.370 -0.010
201607 -0.002 101.844 -0.003
201610 -0.006 102.002 -0.008
201701 -0.005 102.318 -0.006
201704 -0.005 103.029 -0.006
201707 -0.011 103.029 -0.014
201710 -0.003 103.424 -0.004
201801 -0.017 104.056 -0.021
201804 -0.005 105.320 -0.006
201807 -0.011 106.110 -0.014
201810 -0.005 105.952 -0.006
201901 -0.010 105.557 -0.012
201904 -0.008 107.453 -0.010
201907 -0.009 108.243 -0.011
201910 -0.008 107.927 -0.010
202001 -0.005 108.085 -0.006
202004 -0.009 107.216 -0.011
202007 -0.001 108.401 -0.001
202010 0.000 108.638 0.000
202101 0.009 109.192 0.011
202104 0.000 110.851 0.000
202107 -0.001 112.431 -0.001
202110 0.000 113.695 0.000
202201 0.000 114.801 0.000
202204 0.000 118.357 0.000
202207 -0.001 120.964 -0.001
202210 0.000 121.517 0.000
202301 -0.001 121.596 -0.001
202304 0.000 123.571 0.000
202307 -0.001 124.914 -0.001
202310 0.000 125.310 0.000
202401 0.000 125.072 0.000
202404 -0.001 126.890 -0.001
202407 -0.001 128.075 -0.001
202410 -0.001 127.838 -0.001
202501 0.000 127.443 0.000
202504 -0.001 129.102 -0.001
202507 0.000 130.290 0.000
202510 0.000 130.603 0.000
202601 0.000 130.366 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.00 mean?
Quest PharmaTech (QPTFF) has a Cyclically Adjusted FCF per Share of $0.00 as of Jan. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Quest PharmaTech and its competitors.
Is Quest PharmaTech's Cyclically Adjusted FCF per Share too high?
Quest PharmaTech's current Cyclically Adjusted FCF per Share is $0.00.
How does Quest PharmaTech's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Quest PharmaTech's Cyclically Adjusted FCF per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Quest PharmaTech and its competitors. Quest PharmaTech's current Cyclically Adjusted FCF per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current Cyclically Adjusted FCF per Share of $0.00. The current Cyclically Adjusted FCF per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current Cyclically Adjusted FCF per Share is $0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest PharmaTech Business Description

Other Exchanges QPT:Canada
Address 4342- 97 Street NW, Edmonton, AB, CAN, T6E 5R9
Quest PharmaTech Inc is developing targeted cancer therapy with its product (MAb AR9.6), under development for a novel target (truncated O-glycans on MUC16) discovered at the University of Nebraska Medical Center.